MedTrace Logo

Impact of a Nutritional Intervention Based on Moroccan Dietary Habits on the Glycemic Control of Type 2 Diabetics

NCT07404280 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-12

No results posted yet for this study

Summary

The goal of this study is to learn if a nutritional intervention adapted to Moroccan dietary habits can improve blood sugar control in adults with Type 2 Diabetes. The main questions it aims to answer are:

* Does a personalized diet based on Moroccan culinary traditions improve long-term blood sugar levels (HbA1c)?
* How does this intervention affect daily blood sugar fluctuations measured as interstitial glucose?
* Does the intervention lead to changes in body measurements, such as weight and Body Mass Index (BMI)?

Participants will:

* Wear a Continuous Glucose Monitor (CGM) to track sugar levels in real-time.
* Keep a detailed food diary of all foods and drinks consumed.
* Follow their usual diet for the first 7 days to establish a baseline.
* Receive personalized dietary advice specifically tailored to Moroccan food habits.
* Return for clinical check-ups at 14, 90, and 180 days for blood tests and body measurements.

Conditions

  • Type 2 Diabetes (T2DM)

Interventions

BEHAVIORAL

Moroccan-Adapted Nutritional Plan

The intervention consists of a structured diet plan that integrates traditional Moroccan ingredients and cooking methods while optimizing for glycemic control. It involves: * Personalized meal planning based on individual food diaries. * Education on carbohydrate counting and portion sizes within the Moroccan culinary context. * Use of Continuous Glucose Monitoring (CGM) data to provide real-time feedback on how specific Moroccan meals affect the participant's glucose levels.

Sponsors & Collaborators

  • Avicenna Military Hospital

    lead OTHER

Principal Investigators

  • Hicham Baïzri · Department of Endocrinology, Diabetology and Metabolic Diseases, Avicenne Military Hospital, Marrakech, Morocco

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2026-06-30
Completion
2026-09-30

Countries

  • Morocco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07404280 on ClinicalTrials.gov